News

The company has collaborated with the University of California, San Francisco marking the first collaboration in the entrepreneurial network of research partnerships. Pfizer Worldwide Research & Development president

According to the company, increased demand from customers in the pharmaceutical, food and cosmetic industries were the primary contributors for revenue growth during the period. China Ruitai has

Strasbourg, France-based NovAliX Group is focusing on the development of enabling chemistry and biophysical technologies to support the pharmaceutical industry’s outsourcing needs from discovery to manufacturing. Heidelberg, Germany-based

Generally, the committee provides non-binding recommendations for consideration by FDA, with the final decision on approval made by FDA. The FDA has assigned Benlysta a Prescription Drug User

LAB Research has posted a net loss of C$2.64m for the third quarter 2010, or C$0.05 loss per diluted share, compared to net loss of C$1.7m, or C$0.09

Nautilus Neurosciences and Tribute Pharma claimed that a new, water-soluble, buffered diclofenac potassium powder – Cambia is the only prescription non – steroidal anti-inflammatory drug (NSAID) available for

The co-promotion agreement enables Quintiles and Kadrige to develop Web-Call centers, which allow medical sales representatives to train or call healthcare professionals on a full-time basis. Kadrige and

Jiangbo Pharma has posted a net income of $10.57m for the first quarter 2010, or $0.29 per diluted share, compared to net income of $1.97m, or $1.68 loss

Ono Pharma’s Phase 2 comparison study is designed to demonstrate efficacy and safety of subcutaneous methylnaltrexone in Japanese subjects. The drug, designated ONO-3849 in Japan, is being evaluated